Get the Stockscreener App
2.37
3.49%
0.08
After Hours:
2.37
Stereotaxis Inc stock is traded at $2.37, with a volume of 246.25K.
It is up +3.49% in the last 24 hours and up +6.76% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$2.29
Open:
$2.33
24h Volume:
246.25K
Relative Volume:
0.77
Market Cap:
$200.81M
Revenue:
$25.14M
Net Income/Loss:
$-21.57M
P/E Ratio:
-8.7778
EPS:
-0.27
Net Cash Flow:
$-12.23M
1W Performance:
+3.49%
1M Performance:
+6.76%
6M Performance:
+32.40%
1Y Performance:
+26.74%
1-Day Range:
$2.27
$2.40
1-Week Range:
$2.21
$2.40
52-Week Range:
$1.66
$3.29
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.37 | 200.81M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
State Street Corp Acquires 36,518 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World
Charles Schwab Investment Management Inc. Boosts Stock Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World
STXS Stock Up Post NMPA Nod for Cardiovascular Care With Magbot - MSN
Stereotaxis (STXS) Stock Surges Amid Positive Ratings in Medical Device Sector - GuruFocus.com
Stereotaxis (NYSEAMERICAN:STXS) Shares Down 2.2%Here's What Happened - MarketBeat
Items Tagged with 'endovascular robotics' - BioWorld Online
Items Tagged with 'atrioventricular nodal reentrant tachycardia' - BioWorld Online
China clears Stereotaxis/Microport’s robotic ablation catheter - BioWorld Online
NMPA approves Stereotaxis and MicroPort’s ablation catheter - Yahoo Finance
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA - GlobeNewswire
Stereotaxis Secures Crucial NMPA Approval for Revolutionary Magnetic Ablation Catheter in China - StockTitan
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems - GlobeNewswire
Stereotaxis? GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems - Marketscreener.com
Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025 - Seeking Alpha
Stereotaxis surgical robot gets regulatory nod in China - Robot Report
Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Pre-Market Momentum For Stereotaxis (STXS) Following Key Approval - Stocks Telegraph
Stereotaxis’ Genesis Surgical Robot OK’ed in China - MPO-mag
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China - GlobeNewswire
Stereotaxis Secures China NMPA Approval for Genesis Robotic Surgery System - StockTitan
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System - GlobeNewswire
Stereotaxis Genesis Robotic System Debuts at Portugal's Leading Cardiac Center | STXS Stock News - StockTitan
FY2024 EPS Estimates for Stereotaxis Reduced by Roth Capital - MarketBeat
Stereotaxis Inc (STXS) Quarterly 10-Q Report - Quartzy
STXS Stock Drops 5% Despite Strong Buy Ratings from Analysts - GuruFocus.com
Stereotaxis Reports Strong Q3 Growth in Robotics - Yahoo Finance
Stereotaxis Inc. (STXS) Reports Q3 Loss, Tops Revenue Estimates - MSN
Stereotaxis, Inc. (AMEX:STXS) Q3 2024 Earnings Call Transcript - Insider Monkey
Stereotaxis Reports 2024 Third Quarter Financial Results - The Manila Times
Stereotaxis earnings missed by $0.03, revenue topped estimates - Investing.com UK
Stereotaxis Q3 Revenue Surges 18% as GenesisX Robotic System Gains CE Mark | STXS Stock News - StockTitan
Kansas hospital begins robotic heart program with Stereotaxis surgical robot - Robot Report
Robotic Catheter Systems Market Expected to See Prominent - openPR
Stereotaxis Inc (STXS) Q3 2024: Everything You Need To Know Ahea - GuruFocus.com
Kansas health centre adopts Stereotaxis’ endovascular robot - Medical Device Network
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology - GlobeNewswire
Stereotaxis Genesis Robot System Launches at Kansas Health, Marks Major Expansion | STXS Stock News - StockTitan
Global Medical Robot Market to Reach USD 38701.5 Million by 2034 at a 12.9% of CAGR, Driven by Break - PharmiWeb.com
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024 - GlobeNewswire
STXSStereotaxis, Inc. Latest Stock News & Market Updates - StockTitan
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation - GlobeNewswire
Congenital Heart Defect Devices Market Advancements Highlighted by Report 2024: Size, Growth, Key Players, ... - WhaTech
Electrophysiology Catheters Market 2024: Growth Drivers, Technological Innovations, and Competitive Landscape - WhaTech
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):